How Tirzepatide Works (Mechanism of Action) Tirzepatide is a dual GIP/GLP-1 receptor agonist meaning it works on two appetite-regulating hormones instead of one
Prominent mid-sized biopharma firms such as Zealand Pharma, Viking Therapeutics, and Structure Therapeutics have become major beneficiaries of this trend, advancing innovative compounds that promise to complement or outperform current GLP-1 therapies
If nausea is severe enough to prevent you from eating adequate nutrition or staying hydrated, notify your healthcare team immediatelyPlexusDx patients can reach out to discuss dose timing changes or explore whether compounded oral semaglutide or the Microdose GLP-1 Protocol at $129/month might be better tolerated by your system
These effects, in combination, support weight management and glycemic control in patients with obesity and type 2 diabetes ( 1, 3 )
Ahmann A, Chow F, Vivian F, et al
Peripheral neuropathy may take 36 months to improve, and some patients experience incomplete recovery, particularly if treatment was delayed